BMJ Evidence-Based Medicine

Papers
(The H4-Index of BMJ Evidence-Based Medicine is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis374
COVID-19 and the US response: accelerating health inequities126
Is there a smoker’s paradox in COVID-19?85
Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil83
Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review58
Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making48
Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis47
Patient-reported outcome measures (PROMs) as proof of treatment efficacy42
Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent41
Asthma and COVID-19: review of evidence on risks and management considerations37
Maternal caffeine consumption and pregnancy outcomes: a narrative review with implications for advice to mothers and mothers-to-be36
Summarising good practice guidelines for data extraction for systematic reviews and meta-analysis33
Blinding in randomised clinical trials of psychological interventions: a retrospective study of published trial reports33
Transparency of COVID-19 vaccine trials: decisions without data31
Misleading clinical evidence and systematic reviews on ivermectin for COVID-1931
Characteristics, quality and volume of the first 5 months of the COVID-19 evidence synthesis infodemic: a meta-research study29
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression27
Making care fit manifesto21
Thrombolysis with alteplase 3–4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances21
Postmarketing studies: can they provide a safety net for COVID-19 vaccines in the UK?21
Understanding of research results, evidence summaries and their applicability—not critical appraisal—are core skills of medical curriculum20
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review20
Sacubitril, valsartan and SARS-CoV-220
Factors influencing estimated effectiveness of COVID-19 vaccines in non-randomised studies20
0.053366899490356